Browse Drug Recalls
295 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 295 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 295 FDA drug recalls in AR.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 14, 2017 | BUPIVacaine HCl 0.2% IN 0.9% Sodium Chloride 250 mL Bag Preservative Free (To... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Succinylcholine Chloride Injection Solution 10 mL, 200 mg/10 mL (20 mg/mL) Si... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | PHENYLephrine 10 mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmace... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL as citrate 5 mcg/mL in 0.9% Sodium Chloride 1 mL in Single Dose syri... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Sodium Bicarbonate 8.4% Injection Solution 50 mL, 50 mEq (1mEq/mL) Single-Dos... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | ePHEDrine Sulfate 5 mg/mL in NS 5 mL Fill in 12 mL Syringe (25 mg), Rx only, ... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 25 mg/5 mL (5 mg/mL) Single-D... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | morphine sulfate 1 mg per mL in 0.9% Sodium Chloride, (Total morphine Dose 10... | Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have t... | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride 250 mL Bag, Preservative Free... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | MAGNESIUM Sulfate 4 g added to 100 mL 0.9% Sodium Chloride, Total Approximate... | Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have t... | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Hydromorphone 0.5 mg/mL in 0.9% Sodium Chloride 1 mL Fill in 3 mL BD syringe,... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL 2 mcg/mL + BUPIvacaine 0.1% PF in 0.9% NS 250 mL, Rx only, SCA Pharm... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | PHENYLephrine 50 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceutic... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL 10 mcg/mL PF in NS 1 mL Fill in 3 mL syringe, Rx only, SCA Pharmaceu... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL 2 mcg/mL + BUPIvacaine 0.125% PF in 0.9% Sodium Chloride 250 mL, Rx ... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Glycopyrrolate Injection Solution, 1 mL 0.2 mg/1 mL (0.2 mg/mL) Single-Dose S... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | ceFAZolin 3 g added to 100 mL 0.9% Sodium Chloride, Total Approximate Volume ... | Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have t... | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL (as citrate) 10 mcg per mL in 0.9% Sodium Chloride, (Total fentaNYL... | Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have t... | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Rocuronium Bromide Injection Solution 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | BUPIVacaine HCl 0.125% In 250 mL 0.9% Sodium Chloride Bag, Preservative Free ... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL (as citrate) 5 mcg/mL In 250 mL 0.9% Sodium Chloride Injection Bag ... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL 2 mcg/mL+Bupivacaine 0.0625% PF in 0.9% Sodium Chloride 250 mL, Rx o... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | Diltiazem 125 mg in 0.9% Sodium Chloride, 1 mg per mL, Total Volume 125 mL Si... | Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have t... | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | PHENYLephrine 200 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuti... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL 2 mcg/mL + Ropivacaine 0.2% PF in NS 250 mL, Rx only, SCA Pharmaceut... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | fentaNYL (as citrate) 10 mcg per mL in 0.9% Sodium Chloride 250 mL Bag, Rx on... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syr... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | PHENYLephrine 20 mg in 0.9% Sodium Chloride 250 mL Bag, Rx only, SCA Pharmace... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | PHENYLephrine HCl 60 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmace... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jul 14, 2017 | Phenylephrine HCL in 0.9% Sodium Chloride 10 mL, 1 mg/10 mL (100 mcg/mL) Sing... | Lack of Sterility Assurance. | Class II | Cantrell Drug Company |
| Jul 14, 2017 | PHENYLephrine 40 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceutic... | Lack of Assurance of Sterility; product has the potential to leak. | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMol (14.67 mEq K... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 100mL 0.9% Sodium Chloride injectable,20 mcg per mL,... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg (Final Concentrat... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volum... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectable, 4g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volum... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | HYDROmorphone HCL in 0.9% Sodium Chloride injectable, 0.2 mg per ml, Total Vo... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| Feb 3, 2017 | Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use Only, Rx Onl... | Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydr... | Class I | SCA Pharmaceuticals |
| Feb 3, 2017 | Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate Volume ... | Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydr... | Class I | SCA Pharmaceuticals |
| Feb 3, 2017 | Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, ... | Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydr... | Class I | SCA Pharmaceuticals |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.